A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes.
About This Bill
Committee
Latest Action · August 4, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The Stop Superbugs Act directs the National Institute of Allergy and Infectious Diseases to award a competitive grant to the Antibiotic Resistance Leadership Group to establish a clinical research network focused on antibiotic resistance. The network will work to speed up recruitment of trial participants, conduct outreach in community settings, pair new diagnostic tools with experimental drugs during testing, and develop ways to measure patient experiences in clinical studies. This legislation affects researchers, clinical trial participants, and healthcare institutions working on antibiotic resistance solutions. The bill authorizes whatever funding is necessary to support these efforts, though no specific dollar amount is specified. The competitive grant structure means organizations will need to apply and compete for the funding to establish and operate this research network.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.